patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
teclistamab
Marketedupdated 2mo agoby Janssen Biotech Inc
Approvedcommunity read0 votes
all catalysts(11)
approval · 11
Oct 25, 2022
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Aug 9, 2023
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Nov 16, 2023
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Feb 20, 2024
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
May 28, 2024
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Jul 2, 2024
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Nov 22, 2024
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Dec 2, 2024
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Aug 19, 2025
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Oct 2, 2025
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
Mar 5, 2026
approval
TECVAYLI (TECLISTAMAB-CQYV) — FDA approval
teclistamab
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that